Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades
Related CELG
Is More M&A On The Way For Large-Cap Biotechs?
Morgan Stanley Raises Price Target On Celgene, Still Highlights Several Risks
Gilead Gets Wall Street Love After Q2 Earnings Beat (Investor's Business Daily)
Related FB
Facebook Beat Earnings Estimates, So Why Aren't Investors Impressed?
Wednesday's After-Hours Movers Led By Facebook, Whole Foods Market, Western Digital, Unilife & Qorvo
Key Takeaways from Facebook's Q2 Earnings Report - Stocks in the News (Zacks)

Analysts at Deutsche Bank upgraded Celgene (NASDAQ: CELG) from “hold” to “buy.” The target price has been raised from $105.00 to $143.00. Celgene closed at $115.95 yesterday.

Analysts at Argus Research upgraded Facebook (NASDAQ: FB) from “hold” to “buy.” The target price for Facebook is set to $36.00. Facebook shares closed at $27.07 yesterday.

Stifel Nicolaus upgraded Teradata (NYSE: TDC) from “hold” to “buy.” The target price for Teradata is set to $63. Teradata's shares closed at $51.89 yesterday.

JP Morgan upgraded Mobile TeleSystems (NYSE: MBT) from “neutral” to “overweight.” Mobile TeleSystems' shares closed at $19.84 yesterday.

Latest Ratings for CELG

DateFirmActionFromTo
Jul 2015Morgan StanleyMaintainsEqual-weight
Jul 2015Canaccord GenuityMaintainsBuy
Jul 2015Piper JaffrayMaintainsOverweight

View More Analyst Ratings for CELG
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (CELG + FB)

Get Benzinga's Newsletters